Biovie Inc. (BIVIW) SEC Filings — 2025
17 SEC filings for Biovie Inc. (BIVIW) in 2025.
Filings
- BioVie Inc. Files 8-K on Officer/Director Changes & Compensation — 8-K · Nov 13, 2025
- BioVie Inc. Files 8-K on Shareholder Vote Matters — 8-K · Nov 12, 2025
- BIOVIE's Q3 Loss Widens Amid R&D Surge, Cash Boosted by Equity Raise — 10-Q · Nov 10, 2025
- BioVie Seeks Shareholder Approval for Director Slate, Auditor, and Equity Plan Boost — DEF 14A · Sep 25, 2025
- BioVie Inc. Files 2025 10-K — 10-K · Aug 15, 2025
- BioVie Inc. Files 8-K: Material Agreement and Equity Sales — 8-K · Aug 11, 2025
- BIOVIE Amends S-1/A, Signals Continued Clinical Development Push — S-1/A · Aug 4, 2025
- BioVie Inc. Reports Board Changes and Officer Appointments — 8-K · Jul 23, 2025
- BIOVIE Amends S-1/A, Signaling Capital Raise Efforts — S-1/A · Jul 22, 2025
- BIOVIE Amends S-1/A, Signaling Capital Structure Adjustments — S-1/A · Jul 11, 2025
- BioVie Files S-1 for Continuous Offering, Signaling Capital Raise Intent — S-1 · Jul 3, 2025
- BioVie Inc. Reports Material Modification to Security Holder Rights — 8-K · Jun 27, 2025
- BioVie Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jun 24, 2025
- BioVie Seeks Shareholder Nod for Reverse Stock Split — DEF 14A · Jun 2, 2025
- BioVie Inc. Files Q1 2025 10-Q — 10-Q · May 12, 2025
- BioVie Inc. Relocates HQ, Reports Officer & Director Changes — 8-K · Mar 28, 2025
- BioVie Inc. Files 10-Q for Period Ending Dec 31, 2024 — 10-Q · Feb 11, 2025